Kingworld Medicines Group Limited

HKEX:1110.HK

0.61 (HKD) • At close June 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q22008 Q4
Revenue 534.994526.088525.642553.017538.054419.647432.086415.3452.435292.948458.886519.042522.295556.548522.377509.111636.06417.467346.55366.998341.284319.039300.177254.586332.423352.76352.76342.781319.023319.023159.512278.209139.104
Cost of Revenue 401.808388.828399.666398.328394.123285.951302.059281.729282.205183.024336.948373.577385.083382.263347.807360.51449.04280.915235.2251.571263.265240.748231.016192.568254.106270.837270.837262.365248.95248.95124.475217.882108.941
Gross Profit 133.186137.26125.976154.689143.931133.696130.027133.571170.23109.924121.938145.465137.212174.285174.57148.601187.02136.552111.35115.42778.01978.29169.16162.01878.31781.92381.92380.41670.07470.07435.03760.32730.163
Gross Profit Ratio 0.2490.2610.240.280.2680.3190.3010.3220.3760.3750.2660.280.2630.3130.3340.2920.2940.3270.3210.3150.2290.2450.230.2440.2360.2320.2320.2350.220.220.220.2170.217
Reseach & Development Expenses 10.8516.74212.4076.4337.4358.0847.1986.2087.9115.3468.7076.3658.2365.6366.8266.0025.4582.3554.972.4450000000000000
General & Administrative Expenses 47.94942.70872.18547.34759.2645.31353.143.54465.6446.91958.99946.22152.4541.66852.51433.65534.82137.05730.19235.96418.04725.25919.31720.03715.13218.41618.41618.84812.73712.7376.36810.2215.11
Selling & Marketing Expenses 50.27448.56548.154.66251.05149.40151.7847.73490.2542.757.654.68366.05189.02290.37871.72784.66264.46757.7243.75354.38833.34638.53431.75237.27439.18939.18935.4532.43132.43116.21529.18914.595
SG&A 101.33391.273120.726102.009111.35494.714104.9391.278157.17189.3118.758100.968121.342130.528146.036105.382123.148101.52491.02979.71775.01958.60560.00951.78954.55657.60557.60554.29845.16745.16722.58439.4119.705
Other Expenses -10.773-18.684-43.758000000006.1916.1917.2697.2698.8758.8751.2351.2352.7942.794-12.272-12.272-3.479-3.479-3.181-3.181-1.08136.887-53.448-26.724-46.674-23.337
Operating Expenses 101.41179.33189.37588.453116.27483.22999.33385.85152.66558.603103.97187.94106.041124.076120.04498.178132.73293.93388.92779.13649.84353.02730.73138.86239.4454.42454.42453.21782.054-8.281-4.14-7.265-3.632
Operating Income 31.77557.92936.60157.90942.66337.67727.03944.20211.19354.6813.05453.35419.37943.47815.94146.72762.43340.01119.48733.69621.47228.0613.43515.51428.38732.93832.93839.25333.18733.18716.59428.18214.091
Operating Income Ratio 0.0590.110.070.1050.0790.090.0630.1060.0250.1870.0280.1030.0370.0780.0310.0920.0980.0960.0560.0920.0630.0880.0450.0610.0850.0930.0930.1150.1040.1040.1040.1010.101
Total Other Income Expenses Net 8.278-2.463-0.37-2.55-0.143-4.5083.216-6.0071.252-4.01-4.205-2.731.701-0.167-3.403-8.973-5.059-1.6177.563-5.394-0.7760.1426.6269.09711.263-1.31-1.31-2.345-4.016-4.016-2.008-4.805-2.403
Income Before Tax 40.05355.46636.23157.65525.35542.22928.89140.54325.57345.31819.29950.5128.19242.18845.57337.75450.6538.39423.0228.30225.11523.55238.60324.61139.6531.62931.62936.90829.17129.17114.58623.37711.688
Income Before Tax Ratio 0.0750.1050.0690.1040.0470.1010.0670.0980.0570.1550.0420.0970.0540.0760.0870.0740.080.0920.0660.0770.0740.0740.1290.0970.1190.090.090.1080.0910.0910.0910.0840.084
Income Tax Expense 11.2079.84622.3389.95416.9167.12611.9656.2586.45713.5457.17812.368.6269.9958.0718.72413.2968.3424.9167.0196.7254.07710.0815.95610.7827.3617.36111.3937.747.743.874.7552.377
Net Income 10.84130.7160.36937.727-1.47224.21310.83719.4821.8669.8510.54232.88513.45727.54828.92322.13726.85720.38114.54117.93418.4519.47528.52218.65528.86824.26824.26825.51621.43221.43210.71618.6229.311
Net Income Ratio 0.020.0580.0010.068-0.0030.0580.0250.0470.0040.0340.0230.0630.0260.0490.0550.0430.0420.0490.0420.0490.0540.0610.0950.0730.0870.0690.0690.0740.0670.0670.0670.0670.067
EPS 0.0190.0520.0010.064-0.0020.040.0180.0320.0030.0160.0170.0530.0220.0440.0460.0360.0430.030.0210.0260.0290.0310.0460.030.0460.0390.0390.0410.0460.0460.0230.0410.021
EPS Diluted 0.0190.0520.0010.064-0.0020.040.0180.0320.0030.0160.0170.0530.0220.0440.0460.0360.0430.030.0210.0260.0290.0310.0460.030.0460.0390.0390.0410.0460.0460.0230.0410.021
EBITDA 38.7561.70924.18964.33356.95750.43439.89456.56920.70769.48826.97267.26333.43556.85828.27858.873.97951.5331.93542.32422.36628.8914.26616.20229.14333.73333.73340.06433.75133.75116.87628.66314.331
EBITDA Ratio 0.0720.1170.0460.1160.1060.120.0920.1360.0460.2370.0590.130.0640.1020.0540.1150.1160.1230.0920.1150.0660.0910.0480.0640.0880.0960.0960.1170.1060.1060.1060.1030.103